Captor Therapeutics S.A.

WAR:CTX Poland Biotechnology

Market Cap

$107.31 Million

zł446.21 Million PLN

Market Cap Rank

#19718 Global

#102 in Poland

Share Price

zł81.00

Change (1 day)

+2.53%

52-Week Range

zł31.40 - zł87.60

All Time High

zł202.00

Captor Therapeutics S.A. - Asset Resilience Ratio

Latest as of September 2025: 71.95%

Captor Therapeutics S.A. (CTX) has an Asset Resilience Ratio of 71.95% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

zł32.05 Million

Cash + Short-term Investments

Total Assets

zł44.54 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2022)

This chart shows how Captor Therapeutics S.A.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Captor Therapeutics S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	zł0.00	0%
Short-term Investments	zł32.05 Million	71.95%
Total Liquid Assets	zł32.05 Million	71.95%

Asset Resilience Insights

Very High Liquidity: Captor Therapeutics S.A. maintains exceptional liquid asset reserves at 71.95% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.